Gastroesophageal Reflux Treatment in Scleroderma
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Systemic Sclerosis
Related studies linked through entity extraction aliases.
Treatment and Prevention of Progression of Interstitial Lung Disease in Systemic Sclerosis
- Status
- UNKNOWN
- Phase
- N/A
Conception of an ICF Core Set for Systemic Sclerosis
- Status
- COMPLETED
- Phase
- N/A
Development and Prevention of Pulmonary Hypertension in Systemic Sclerosis
- Status
- UNKNOWN
- Phase
- N/A
Prevention and Treatment of Digital Ulcers in Systemic Sclerosis
- Status
- UNKNOWN
- Phase
- N/A
Improvement of Hand Dysfunction by Arthritis in Systemic Sclerosis
- Status
- UNKNOWN
- Phase
- N/A
Development and Prevention of Severe Heart Disease in Systemic Sclerosis
- Status
- UNKNOWN
- Phase
- N/A
Oral Health and People With Systemic Sclerosis
- Status
- COMPLETED
- Phase
- N/A
Effects of Intensive Aerobic and Muscle Endurance Exercise in Patients With Systemic Sclerosis - a Pilot Study
- Status
- COMPLETED
- Phase
- NA
Assessment of the Subcutaneous Reinjection of Human Autologous Adipose-derived Stromal Vascular Fraction (Celution® System) in the Hands of Patients Suffering From Systemic Sclerosis
- Status
- COMPLETED
- Phase
- NA
Clinical Trial of Probiotics in Systemic Sclerosis Associated Gastrointestinal Disease
- Status
- UNKNOWN
- Phase
- PHASE2
IVIG Treatment in Systemic Sclerosis
- Status
- UNKNOWN
- Phase
- NA
Rituximab in Systemic Sclerosis
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
The CARRA Registry
- Status
- COMPLETED
- Phase
- N/A
Sacroiliitis in Systemic Sclerosis
- Status
- COMPLETED
- Phase
- N/A
Belimumab for the Treatment of Diffuse Cutaneous Systemic Sclerosis
- Status
- COMPLETED
- Phase
- PHASE2
Proof of Biological Activity of SAR100842 in Systemic Sclerosis
- Status
- COMPLETED
- Phase
- PHASE2
Cyclophosphamide Systemic Sclerosis Associated Interstitial Lung Disease
- Status
- COMPLETED
- Phase
- PHASE3
Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Patients With Systemic Sclerosis With Interstitial Lung Disease
- Status
- TERMINATED
- Phase
- PHASE2
IL1-TRAP, Rilonacept, in Systemic Sclerosis
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2